These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24942493)

  • 21. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.
    Lövgren T; Eloranta ML; Båve U; Alm GV; Rönnblom L
    Arthritis Rheum; 2004 Jun; 50(6):1861-72. PubMed ID: 15188363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of BLyS on the activity of peripheral B lymphocytes mediated by BLyS receptors in patients with systemic lupus erythematosus.
    Cheng Y; Yan S; Zhao W; Huang Q; Lian L; Wei W
    Scand J Clin Lab Invest; 2013 Mar; 73(2):141-7. PubMed ID: 23336587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocyte CD64 expression as a novel biomarker for the disease activity of systemic lupus erythematosus.
    Kikuchi-Taura A; Yura A; Tsuji S; Ohshima S; Kitatoube A; Shimizu T; Nii T; Katayama M; Teshigawara S; Yoshimura M; Kudo-Tanaka E; Harada Y; Matsushita M; Hashimoto J; Saeki Y
    Lupus; 2015 Sep; 24(10):1076-80. PubMed ID: 25804673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1β and LFA-1.
    Hagberg N; Berggren O; Leonard D; Weber G; Bryceson YT; Alm GV; Eloranta ML; Rönnblom L
    J Immunol; 2011 May; 186(9):5085-94. PubMed ID: 21430220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus.
    Vallin H; Perers A; Alm GV; Rönnblom L
    J Immunol; 1999 Dec; 163(11):6306-13. PubMed ID: 10570325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes.
    Leonard D; Eloranta ML; Hagberg N; Berggren O; Tandre K; Alm G; Rönnblom L
    Ann Rheum Dis; 2016 Sep; 75(9):1728-34. PubMed ID: 26493814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.
    Collins CE; Gavin AL; Migone TS; Hilbert DM; Nemazee D; Stohl W
    Arthritis Res Ther; 2006; 8(1):R6. PubMed ID: 16356193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.
    Ritterhouse LL; Crowe SR; Niewold TB; Merrill JT; Roberts VC; Dedeke AB; Neas BR; Thompson LF; Guthridge JM; James JA
    Arthritis Rheum; 2011 Dec; 63(12):3931-41. PubMed ID: 22127709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus.
    Bayry J; Lacroix-Desmazes S; Delignat S; Mouthon L; Weill B; Kazatchkine MD; Kaveri SV
    Arthritis Rheum; 2003 Dec; 48(12):3497-502. PubMed ID: 14674000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus.
    Mellor-Pita S; Citores MJ; Castejon R; Yebra-Bango M; Tutor-Ureta P; Rosado S; Andreu JL; Vargas JA
    Cytometry B Clin Cytom; 2009 Jul; 76(4):261-70. PubMed ID: 19199277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis.
    Kawasaki A; Tsuchiya N; Fukazawa T; Hashimoto H; Tokunaga K
    Genes Immun; 2002 Nov; 3(7):424-9. PubMed ID: 12424625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-interferon alpha treatment in SLE.
    Kirou KA; Gkrouzman E
    Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased interferon-1α, interleukin-10 and BLyS concentrations as clinical activity biomarkers in systemic lupus erythematosus.
    Fernández Matilla M; Grau García E; Fernández-Llanio Comella N; Chalmeta Verdejo I; Ivorra Cortés J; Castellano Cuesta JA; Román Ivorra JA
    Med Clin (Barc); 2019 Sep; 153(6):225-231. PubMed ID: 30795903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus.
    Baranda L; de la Fuente H; Layseca-Espinosa E; Portales-Pérez D; Niño-Moreno P; Valencia-Pacheco G; Abud-Mendoza C; Alcocer-Varela J; González-Amaro R
    Rheumatology (Oxford); 2005 Dec; 44(12):1507-13. PubMed ID: 16251219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
    Cheema GS; Roschke V; Hilbert DM; Stohl W
    Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.
    Cederblad B; Blomberg S; Vallin H; Perers A; Alm GV; Rönnblom L
    J Autoimmun; 1998 Oct; 11(5):465-70. PubMed ID: 9802930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [B lymphocyte stimulator in systemic lupus erythematosus].
    Mercado U
    Rev Med Inst Mex Seguro Soc; 2012; 50(4):349-50. PubMed ID: 23234733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid-induced leucine zipper expression is associated with response to treatment and immunoregulation in systemic lupus erythematosus.
    Mohammadi S; Ebadpour MR; Sedighi S; Saeedi M; Memarian A
    Clin Rheumatol; 2017 Aug; 36(8):1765-1772. PubMed ID: 28601944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.